Release Date: 27/07/11 08:56 Summary: Exploration Update and Capital Raising Price Sensitive: Yes Download Document 3.04MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%